This study aims to investigate differences in serum ischemia-modified albumin (IMA) and adjusted IMA levels among cases of healthy intrauterin pregnancies, threatened abortions, and missed abortions. In this prospective case-control study, a total of 90 participants were included, distributed into three groups: missed abortion (n = 30), threatened abortion (n = 30), and intrauterin healthy pregnancy (n = 30). IMA and adjusted IMA values were calculated for each group. Our findings revealed no significant differences in serum IMA and adjusted IMA concentrations among the three groups. Additionally, there were no correlation observed between IMA levels, adjusted IMA levels, and maternal age, body mass index (BMI), white blood cell (WBC) count, neutrophil count, lymphocyte count, platelet count, neutrophil-to-lymphocyte ratio (NLR), platelet-to lymphocyte ratio (PLR), mean corpuscular volume (MCV), and red cell distribution width (RDW). The study concludes that IMA lacks a reliable capacity to differentiate between potential healthy intrauterine pregnancies, threatened abortions, or missed abortions during the first trimester. These results highlight the need for exploring alternative biomarkers that may offer greater specificity in distinguishing various pregnancy outcomes in early gestation.
Çendek et al. (Mon,) studied this question.